D-1740-2019 Class II Terminated
FDA drug recall D-1740-2019 was initiated by US Pharmaceuticals Inc. on Jul 11, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process. The recall status is terminated (terminated Jun 25, 2020). Affected quantity: 147 cases.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 21, 2019
- Initiation Date
- Jul 11, 2019
- Termination Date
- Jun 25, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 147 cases
Product description
Wonder Freeze Pain Releiving Gel with ILEX, Menthol 5%, packaged in a) 3 OZ /85 g (UPC 0 99528 35903 5); b) 4 OZ / 113 g (UPC 0 99528 31504 8); c) 16 OZ / 454 g (UPC 0 99528 31516 1); Manufactured For: Wonder Laboratories, 115 S.C.T. Ct., White House TN. 37188.
Reason for recall
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot # a) 21J18, EXP 07/2021 b) 42H18, EXP 06/2021; c) 32H18, EXP 6/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1740-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026